Ryan Nicholson Insider Trading $DLB Dolby Laboratories, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ryan Nicholson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan Nicholson. Ryan Nicholson is VP, Corporate Controller in Dolby Laboratories, Inc. ($DLB).
Ryan Nicholson in Dolby Laboratories, Inc.
Industry: PATENT OWNERS & LESSORS [6794]
Position of Ryan Nicholson: VP, Corporate Controller
Holdings: 10,223 shares
Current Value: $486,717
Latest Transaction: Feb 04 2021
$DLB Market Capitalization: $4.88B
$DLB Previous Close: $47.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ryan Nicholson in Dolby Laboratories, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2021 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 91.01 | 2,237 | 203,583 | 10,223 | 12.5 K to 10.2 K (-17.95 %) |
| Dec 21 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 91.03 | 217 | 19,754 | 12,460 | 12.7 K to 12.5 K (-1.71 %) |
| Dec 17 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 92.08 | 195 | 17,956 | 12,677 | 12.9 K to 12.7 K (-1.51 %) |
| Dec 17 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Grant | A | 0.00 | 4,500 | 0 | 12,872 | 8.4 K to 12.9 K (+53.75 %) |
| Dec 17 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 90.86 | 444 | 40,342 | 8,372 | 8.8 K to 8.4 K (-5.04 %) |
| Aug 27 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Option Exercise | M | 28.24 | 395 | 11,155 | 0 | |
| Aug 27 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 70.62 | 395 | 27,894 | 8,789 | 9.2 K to 8.8 K (-4.30 %) |
| Aug 27 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Buy | M | 28.24 | 395 | 11,155 | 9,184 | 8.8 K to 9.2 K (+4.49 %) |
| Aug 27 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 70.68 | 506 | 35,762 | 8,789 | 9.3 K to 8.8 K (-5.44 %) |
| Feb 12 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Option Exercise | M | 25.00 | 1,740 | 43,500 | 0 | |
| Feb 12 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 71.59 | 1,180 | 84,480 | 8,931 | 10.1 K to 8.9 K (-11.67 %) |
| Feb 12 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 71.63 | 1,740 | 124,636 | 10,111 | 11.9 K to 10.1 K (-14.68 %) |
| Feb 12 2020 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Buy | M | 25.00 | 1,740 | 43,500 | 11,851 | 10.1 K to 11.9 K (+17.21 %) |
| Dec 18 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Option Exercise | A | 68.40 | 10,225 | 699,390 | 10,225 | |
| Dec 18 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 68.40 | 217 | 14,843 | 10,111 | 10.3 K to 10.1 K (-2.10 %) |
| Dec 18 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Grant | A | 0.00 | 2,250 | 0 | 10,328 | 8.1 K to 10.3 K (+27.85 %) |
| Dec 18 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 67.75 | 596 | 40,379 | 8,078 | 8.7 K to 8.1 K (-6.87 %) |
| Sep 18 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Payment of Exercise | F | 64.60 | 182 | 11,757 | 8,579 | 8.8 K to 8.6 K (-2.08 %) |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Option Exercise | M | 45.50 | 5,333 | 242,652 | 2,667 | |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Option Exercise | M | 45.50 | 5,333 | 242,652 | 2,667 | |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 61.05 | 2,864 | 174,853 | 8,761 | 11.6 K to 8.8 K (-24.64 %) |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 61.05 | 2,864 | 174,853 | 8,761 | 11.6 K to 8.8 K (-24.64 %) |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 61.03 | 5,333 | 325,478 | 11,625 | 17 K to 11.6 K (-31.45 %) |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 61.03 | 5,333 | 325,478 | 11,625 | 17 K to 11.6 K (-31.45 %) |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Buy | M | 45.50 | 5,333 | 242,652 | 16,958 | 11.6 K to 17 K (+45.88 %) |
| Aug 28 2019 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Buy | M | 45.50 | 5,333 | 242,652 | 16,958 | 11.6 K to 17 K (+45.88 %) |
Page: 1